Relative Bioavailability of Two Formulations of AKB-6548 and the Food Effect of a New Tablet in Healthy Adult Subjects

NCT02412449 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: AKB-6548 tablet, reference formulation given in the fasted state
DRUG: AKB-6548 tablet, test formulation given in the fasted state.
DRUG: AKB-6548 tablet, test formulation given in the fed state

Sponsor

Akebia Therapeutics